About Company
- Legal Name: Guangdong Raffles PharmaTech Co Ltd
- Registered country: China
- Address: No 3, Binhai 10th Road North, Shihua Dadao Middle, Daya Bay, Huizhou, Guangdong
- Number of employees: 250 - 499
Description:
Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceutical ingredients and intermediates. We are specialized in applying organic catalysts into the process development to lower cost, and to provide cost-effective product and service to customers. With our strong R&D capability and our proprietary organic catalysts, we provide low cost and high quality active pharmaceutical ingredients and intermediates to pharmaceutical companies. We also provide world standard process development, custom synthesis and manufacturing service.
Business Activities
Active Pharmaceutical Ingredients (APIs)
Manufacturer
Contract & Outsourcing Services
Manufacturer
Pharma Chemicals
Manufacturer
Contract Research Organisations Services (CROs)
Manufacturer
Biopharmaceutical Services
Manufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
Key Products/Services
- Pharma Chemicals: (2R,6R)-2,6-diphenyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2R)-2-Piperidine Methanamine, (3S,11aR)-N-(2,4-difluorobenzyl)-6-methoxy-3-methyl-5,7, (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, 1,5,7-Triazabicyclo[4.4.0]dec-5-ene, 1,4,6-Triazabicyclo[3.3.0]oct-4-ene, (4S,5S)-1H-lmidazolium,2- [[(4S,5S)-1,3-dimiethyl-4,5, (S)-a-(Phenylmethyl)-1-pyrrolidinethanamine, (R)-VAPOL HYDROGENPHOSPHATE, (8a,9R)- 10,11-dihydro-Cinchonan-6',9-diol, (9S)-9-(9-phenanthrenyloxy)-Cinchonan-6'-ol, (S)-(–)-a,a-Diphenyl-2-pyrrolidinemethanol trimethylsilyl ether, 2-(diphenylphosphino)-N-(pyridin-2-ylmethyl)ethanamine, (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H- [1,2,4], (5aR,10bS)-(+)-5a,10b-Dihydro-2-(pentafluorophenyl, (5aS, 10bR)-(-)-5a,10b-Dihydro-2-(pentafluorophe, 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, (S)-5-benzyl-2-phenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c], (S)-2-[[(1R,2R)-2-AMINOCYCLOHEXYL]THIOUREIDO] -N-BENZYL-N,3,3-TRIMETHYLBUTANAMIDE, (2S)-2-[[[[3,5-Bis(trifluoromethyl) phenyl]amino], 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea, (2S)-2-amino-N,3,3-trimethyl-N-(phenylmethyl)-ButaN/Amide, (S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl) -3-((1R,2R)-2-(dipropylamino)cyclohexyl)thiour, 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1S,2S)-2-(dimethylamino)cyclohexyl]thiourea, (S)-2-[[(1R,2R)-2-[[[3,5-Bis(tert-butyl)-2-hydroxyphenyl] methylene]amino]cyclohexyl]thioureido], 2-Propanesulfinamide, N-[(1R,2R)-2-[[[[3,5-bis(trifluoromethyl)phenyl]amino] carbonyl]amino]cycloh, (2S)-3,3-DIMETHYL-2-[[(1R,2R)-2-(2-METHYL-5-PHENYL-1-PYRROLYL) CYCLOHEXYL]THIOUREIDO]-N,N-BIS(2-ISO, (R,R)-(+)-Hydrobenzoin, (2S)-2-Piperidine Methanamine, (2S,3S,4S,5R,6R)-6-bromotetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, (3S)-3-Thiophenamine, tetrahydro-, 1,1-dioxide, hydrochloride (1:1), (2S,3R)-2-hydroxy-3-(naphthalen-2-ylmethyl)succinic acid1, (R)-2-((S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-(naphthalen-2-yl)propanoic acid, (S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1-naphthalenone, 1,4-difluoroanthraquinone
Our Products & Services
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment